Blood Establishment Registration and Product Listing for Manufacturers of Human Blood and Blood Products and Licensed Devices

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
Form Form FDA 2830 Blood Establishment Registration and Product Listing	Form and Instruction	Modified	Available
Form Form FDA 2830 Waiver requests	Form and Instruction	Modified	Repair queued
0052_Supporting Statement_2021.pdf	Supporting Statement A	Uploaded 2021-06-10	Repair queued

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
5706	Initial registration	Other-eSystem screen shots	Modified
200689	Waiver requests	Form and Instruction	Modified	Blood Establishment Registration and Product Listing
200689	Waiver requests	Form and Instruction	Modified
200688	Annual review and product listing update of registration	Other-eSystem screen shots	Modified

ICR Details

OMB Control No: 0910-0052	ICR Reference No: 202106-0910-001
Status: Historical Active	Previous ICR Reference No: 201804-0910-015
Agency/Subagency: HHS/FDA	Agency Tracking No: CBER
Title: Blood Establishment Registration and Product Listing for Manufacturers of Human Blood and Blood Products and Licensed Devices
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 07/13/2021
Retrieve Notice of Action (NOA)	Date Received in OIRA: 06/11/2021
Terms of Clearance:

table that charts list comparision

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	07/31/2024	36 Months From Approved	07/31/2021
Responses	2,966	0	2,952
Time Burden (Hours)	1,496	0	1,496
Cost Burden (Dollars)	0	0	0

---

Abstract: The information collection supports statutory requirements under the Federal Food, Drug, and Cosmetic Act governing the registration of blood establishments and the listing of blood products. The information obtained through this collection registration assists FDA with its mandate to inspect facilities and helps to ensure protection of the public health and safety of the nation's blood supply.

---

Authorizing Statute(s): US Code: 21 USC 301 et seq. Name of Law: Federal Food, Drug, and Cosmetic Act
   US Code: 42 USC 262 Name of Law: Public Health Service Act; Regulation of biological products
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	86 FR 10085	02/18/2021
30-day Notice:	Federal Register Citation:	Citation Date:
	86 FR 31316	06/11/2021
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 3

table that charts list of burden

IC Title	Form No.	Form Name
Annual review and product listing update of registration
Initial registration
Waiver requests	Form FDA 2830	Blood Establishment Registration and Product Listing

---

ICR Summary of Burden

table that charts list of burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	2,966	2,952	0	0	14	0
Annual Time Burden (Hours)	1,496	1,496	0	0	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: The information collection reflects agency adjustments. Based on our evaluation of Fiscal Year 2019 data from CBER’s Blood Establishment Registration and Product Listing system, we have adjusted the currently approved burden estimate to reflect an increase in annual product listing updates by 14 responses annually.

---

Annual Cost to Federal Government: $148,200

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 06/11/2021

---